眼痛治療のグローバル臨床試験動向(2014年下半期)

◆英語タイトル:Ocular Pain Global Clinical Trials Review, H2, 2014
◆発行会社/調査会社:GlobalData
◆商品コード:GDHC2259CTIDB
◆発行日:2014年7月28日
◆調査対象地域:グローバル
◆産業分野:製薬、医療
◆ページ数:67
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD7,500 ⇒換算¥847,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の市場調査資料のご購入、委託調査サービスに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[眼痛治療のグローバル臨床試験動向(2014年下半期)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Ocular Pain Global Clinical Trials Review, H2, 2014

Summary

GlobalData’s clinical trial report, “Ocular Pain Global Clinical Trials Review, H2, 2014″ provides data on the Ocular Pain clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ocular Pain. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ocular Pain. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

*** レポート目次(コンテンツ)***

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Ocular Pain 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Ocular Pain to Central Nervous System Clinical Trials 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Ocular Pain to Central Nervous System Clinical Trials 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Subjects Recruited Over a Period of Time 20
Clinical Trials by Sponsor Type 21
Prominent Sponsors 22
Top Companies Participating in Ocular Pain Therapeutics Clinical Trials 23
Prominent Drugs 24
Clinical Trial Profiles 25
Clinical Trial Overview of Top Companies 25
Valeant Pharmaceuticals International, Inc. 25
Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 25
Reata Pharmaceuticals, Inc. 26
Clinical Trial Overview of Reata Pharmaceuticals, Inc. 26
Zeltia, S.A. 27
Clinical Trial Overview of Zeltia, S.A. 27
Ocular Therapeutix, Inc. 28
Clinical Trial Overview of Ocular Therapeutix, Inc. 28
Novartis AG 29
Clinical Trial Overview of Novartis AG 29
Kala Pharmaceuticals, Inc. 30
Clinical Trial Overview of Kala Pharmaceuticals, Inc. 30
InSite Vision Incorporated 31
Clinical Trial Overview of InSite Vision Incorporated 31
Clinical Trial Overview of Top Institutes / Government 32
Virdi Eye Clinic 32
Clinical Trial Overview of Virdi Eye Clinic 32
Isfahan University of Medical Sciences 33
Clinical Trial Overview of Isfahan University of Medical Sciences 33
Qazvin University Of Medical Sciences 34
Clinical Trial Overview of Qazvin University Of Medical Sciences 34
Mahidol University 35
Clinical Trial Overview of Mahidol University 35
Five Key Clinical Profiles 36
Appendix 65
Abbreviations 65
Definitions 65
Research Methodology 66
Secondary Research 66
About GlobalData 67
Contact Us 67
Disclaimer 67
Source 67

List of Tables
Ocular Pain Therapeutics, Global, Clinical Trials by Region, 2014* 6
Ocular Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Ocular Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Ocular Pain Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Ocular Pain Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Ocular Pain Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Ocular Pain Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Proportion of Ocular Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Ocular Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Ocular Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 15
Ocular Pain Therapeutics, Global, Clinical Trials by Phase, 2014* 16
Ocular Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 17
Ocular Pain Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Ocular Pain Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19
Ocular Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 20
Ocular Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 21
Ocular Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 22
Ocular Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 23
Ocular Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 24
Ocular Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2014* 25
Ocular Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Reata Pharmaceuticals, Inc., 2014* 26
Ocular Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Zeltia, S.A., 2014* 27
Ocular Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Ocular Therapeutix, Inc., 2014* 28
Ocular Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 29
Ocular Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Kala Pharmaceuticals, Inc., 2014* 30
Ocular Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by InSite Vision Incorporated, 2014* 31
Ocular Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Virdi Eye Clinic, 2014* 32
Ocular Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2014* 33
Ocular Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Qazvin University Of Medical Sciences, 2014* 34
Ocular Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Mahidol University, 2014* 35

List of Figures
Ocular Pain Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Ocular Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Ocular Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Ocular Pain Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Proportion of Ocular Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Ocular Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Ocular Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 15
Ocular Pain Therapeutics, Global, Clinical Trials by Phase (%), 2014* 16
Ocular Pain Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 17
Ocular Pain Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Ocular Pain Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19
Ocular Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 20
Ocular Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 21
Ocular Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 22
Ocular Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 23
Ocular Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 24
GlobalData Methodology 66

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GDHC2259CTIDB )"眼痛治療のグローバル臨床試験動向(2014年下半期)" (英文:Ocular Pain Global Clinical Trials Review, H2, 2014)はGlobalData社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。